Santiago child entered the month of life in a hospital with a severe and rare hereditary disorder of the immune system that left her totally unprotected body against any disease. The condition is caused by a defect of the antigens HLA class 2, which are molecules essential to trigger the immune system. The first doctors who attended him did not give more than a few weeks of life and proceeded to transfer him to the Garrahan hospital, in the capital of argentina. A month of life we receive to Santiago derived from a hospital in Jujuy, where his family lives and confirm the diagnosis of primary combined immunodeficiency hereditary, explained Dr. Bonduel. Source: Gary Kelly. In view of the results, the responsible intervention specialist decided to resort to an innovative method. Be injected the blood directly through the jugular, so that the stem cells traveled through the bloodstream and implanted in a natural way in the bone marrow of the small. After this type processes, cells settle and begin to proliferate and differentiate themselves, i.e., to produce two hematopoietic cell lines: one, that will be responsible for producing white blood cells, red blood cells and platelets, and the other, the populations of lymphocytes.

This transplantation is the alternative therapy that we can now offer ultimately are in the most delicate stage: we should check if new cells can rebuild lymphocytes that will organize a normal immune response, said the specialist after the intervention. With this new intervention, and waiting to see how the baby develops in the coming weeks, again demonstrating the greater viability of adult stem cells or umbilical cord against the use of embryonic stem cells, without therapeutic results to date. About IVIDA IVIDA born in 2009 and belongs to the IVI, the leading medical institution in Europe in assisted reproduction group. IVIDA collects, processes, Cryo-preserved and stored stem cells from the blood of Umbilical cord (SCU) for the treatment of various diseases such as lymphomas, leukemias and anemias, with the guarantee that will be entirely managed by employees of the company, thus ensuring their traceability and complete control on the process.